MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-17373

  1. 6,278 Posts.
    lightbulb Created with Sketch. 372
    Great situation we find ourselves in.......we have the FDA in their 'delay, dilute & destroy' mode on one side and the 'never respect a patent' chinese on the other. They are notorious for copying patented drugs & therapies and releasing that version as their own. I, like many, wish for that long awaited partnership announcement before our ship takes on too much more water.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.